Penumbra, Inc. (PEN) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Alameda, CA, 미국. 현재 CEO는 Adam Elsesser.
PEN 을(를) 보유 IPO 날짜 2015-09-18, 4,500 명의 정규직 직원, 에 상장 NYSE, 시가총액 $13.04B.
Penumbra, Inc. is a medical device company headquartered in Alameda, California, that designs, develops, manufactures, and markets innovative vascular intervention and neurosurgical products globally. The company specializes in aspiration-based thrombectomy systems for mechanical clot removal, neurovascular embolization coiling systems for treating aneurysms, and neurovascular access systems, marketed under brands including Penumbra System, Penumbra Coil, and Neuron. Its product portfolio also encompasses neurosurgical aspiration tools, peripheral embolization devices, microcatheters, and occlusion devices, along with immersive technology solutions for patient rehabilitation. Penumbra distributes its products through direct sales teams and distributor networks to serve the interventional neuroradiology, neurosurgery, and vascular surgery markets worldwide.